Berna Biotech to divest its veterinary business Gräub AG
Berna Biotech announced that it has reached agreement on the sale of all its shares in the veterinary pharmaceuticals production company Dr. E. Gräub AG. The company will become a subsidiary of VETINVEST GmbH, a German company investing in the field of veterinary medicines.
Berna decided to sell the fully owned Dr. E. Gräub, which employs 40 people, as production and sales of veterinary medicines are not among its core activities. This divestment is an important step towards aligning Berna's portfolio of activities with its strategic priorities.
The transaction will be formally concluded immediately upon approval by the competent competition authorities. Financial details were not disclosed.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.